Subject Author Posted Rep. last R. [desc] Views
libaiyi 2018-11-14 13:21 0   2,031
vishal1721 2018-10-19 09:29 0   1,616
ElMaestro 2018-07-10 18:28 0   1,827
Helmut 2018-06-20 13:45 4 2018-06-20 13:59 3,787
mittyri 2018-02-07 21:02 2 2018-02-09 19:58 3,937
ElMaestro 2018-01-17 13:22 9 2018-01-18 14:23 6,199
Norah 2018-01-16 11:57 5 2018-01-18 09:41 4,183
Helmut 2017-03-03 11:42 4 2017-11-14 14:47 5,181
ElMaestro 2017-10-13 20:29 1 2017-10-13 20:21 3,814
raghavendra_s 2010-06-21 10:02 2 2017-08-02 00:32 6,357
ElMaestro 2017-07-06 22:59 2 2017-07-14 16:24 4,290
ElMaestro 2017-05-10 11:36 1 2017-05-10 10:53 2,939
varadpradhan 2017-05-04 11:20 2 2017-05-09 00:51 3,433
suchit_bhavsar 2017-04-14 08:30 1 2017-04-14 16:17 2,666
Dr_Dan 2016-12-20 09:33 6 2017-03-24 15:19 6,188
UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
19 visitors (0 registered, 19 guests [including 13 identified bots]).
Forum time: 00:58 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5